+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Merck & Co., Inc. - logo

Merck & Co., Inc. is a global healthcare company with operations in more than 140 countries. It offers therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus and other diseases. The company has collaboration agreements with Adaptimmune Therapeutics plc and Agenus; and a research agreement with Proteros Biostructures. Founded in 1891, it is headquartered in Kenilworth, New Jersey.

Pharmaceutical Marketing Market - Global Forecast 2026-2032 - Product Thumbnail Image

Pharmaceutical Marketing Market - Global Forecast 2026-2032

  • Report
  • August 2026
  • 190 Pages
  • Global
From
From
Malignant Pleural Mesothelioma- Pipeline Insight, 2025 - Product Thumbnail Image

Malignant Pleural Mesothelioma- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
From
Global Animal Imaging Market Outlook 2031 - Product Thumbnail Image

Global Animal Imaging Market Outlook 2031

  • Report
  • September 2022
  • 213 Pages
  • Global
From
Staphylococcus Aureus Bacteremia- Pipeline Insight, 2025 - Product Thumbnail Image

Staphylococcus Aureus Bacteremia- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Hepatitis B Vaccine Market Forecasts from 2023 to 2028 - Product Thumbnail Image

Hepatitis B Vaccine Market Forecasts from 2023 to 2028

  • Report
  • November 2023
  • 146 Pages
  • Global
From
LAG-3 Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

LAG-3 Antagonist - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Proto Oncogene Protein C-akt Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Proto Oncogene Protein C-akt Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator